| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.068 | 0.1 |